Delivery Order SPE2DB25D3201-SPE2DB25FNVCB
- Not listed
- The Defense Logistics Agency awarded a $18,993.25 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,726.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a $22,445.54 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This is a firm fixed-price delivery order with an ultimate completion date of May 7, 2025, to be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $43,164.50 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $11,485.75 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.14 to AmerisourceBergen Drug Corp on July 2, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The contract, which is not set-aside and operates under firm fixed pricing, is scheduled for completion by July 3, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $18,736.79 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price, non-competitive delivery order was issued on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a $45,117.27 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product, with an ultimate completion date of June 26, 2025. The contract was awarded on a firm fixed-price basis with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TYPHIM VI (typhoid vaccine) 25 mcg/0.5 mL syringes valued at $55,192.00 on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order represents a small transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product, with a ceiling value of $4,317.62 and an ultimate completion date of July 15, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's facility in...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVCBDelivery Order
The Defense Logistics Agency awarded a $4,513.01 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This contract represents a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive federal contract portfolio focused on fulfilling Defense Health Agency and military medical supply requirements across multiple therapeutic domains, including vaccines, specialty medications, and other critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 7/24/25 |